Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000450 · ClinicalTrials.gov registry record · Phase 4
Naltrexone Maintenance Treatment of Alcoholism
A Phase 4 study, sponsored by The Scripps Research Institute.
- Completed
- Registry status
- Phase 4
- Development phase
- 159
- Enrollment target
NCT00000450 is a Phase 4 study that has completed, run by The Scripps Research Institute. The registered enrollment target is 159 participants.
The verdict
NCT00000450, a Phase 4 study, has completed, sponsored by The Scripps Research Institute.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 159 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the long-term effectiveness of naltrexone treatment in alcohol-dependent patients who respond to short-term treatment. Those who respond to short-term treatment will be randomized to a 1-year, double-blind, placebo-controlled maintenance phase with a 6-month posttreatment followup.
Interventions
- DRUG Naltrexone Tablet
- DRUG Matched Placebo Tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 159 participants |
| Start Date | 1997-04-10 |
| Est. Completion | 2002-02-13 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000450
The ClinicalTrials.gov registry entry for NCT00000450 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 159 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Scripps Research Institute, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Naltrexone Tablet is the first listed.
NCT00000450 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000450 about?
NCT00000450 is a clinical study titled "Naltrexone Maintenance Treatment of Alcoholism". The purpose of this study is to determine the long-term effectiveness of naltrexone treatment in alcohol-dependent patients who respond to short-term treatment. Those who respond to short-term treatment will be randomized to a 1-year, double-blind, placebo-controlled maintenance phase with a 6-month...
What is the current status of trial NCT00000450?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 159 participants. The study started on 1997-04-10. Estimated completion is 2002-02-13.
What interventions are being tested in trial NCT00000450?
The interventions under investigation include: Naltrexone Tablet (DRUG), Matched Placebo Tablet (DRUG).
Who is sponsoring clinical trial NCT00000450?
This trial is sponsored by The Scripps Research Institute, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.